Marco Donia, Professor at University of Copenhagen (Københavns Universitet), shared a post by Gustave Roussy Éducation on LinkedIn, adding:
“Congratulations on a terrific symposium about Cancer Immunotherapy Adverse Events organized by dedicated colleagues at Gustave Roussy Université Paris-Saclay.
Slides on ‘Acute and Long-term Adverse Events Induced by TIL Therapies for Solid Tumors‘ are available.
Comment ‘Slides’ or send me a PM and I will share them with you.
Thanks to the whole organizing committee for the invitation, and to the many brilliant colleagues who made this event possible. In particular, warm thanks to François-Xavier Danlos.”
Quoting Gustave Roussy Éducation
“iTOX 2026 Symposium – a quick look back.
Over the last two days, the 9th edition of the iTOX Symposium brought together a strong community of experts to explore the complexities of immunotherapy-related toxicities.
From emerging treatments and cellular therapies to diagnostic challenges, clinical management, and patient perspectives, the discussions highlighted both the progress made and the questions that remain. The diversity of viewpoints and the quality of exchanges once again underscored the value of interdisciplinary collaboration in this rapidly evolving field.
A particularly engaging edition, with a high level of participation and interaction throughout the sessions.
Many thanks to the speakers, scientific committee, sponsors and all attendees who made these two days so impactful.
We also thank Yasmina Hammadache, Alexia NERFIE and all of the team for organizing this event !
Which topic should be further explored in the next edition ?”
Other articles about Immunotherapy on OncoDaily.
